摘要:目的: 探討深部痛點阻滯在治療頑固性癌痛患者中的作用。 方法 : 將156例頑固性癌痛患者,隨機分為深部痛點阻滯組及對照組,每組78例。深部痛點阻滯組根據疼痛部位,應用軟組織外科學理論找出相應壓痛點,給予痛點深部阻滯治療;對照組找出壓痛點但僅按三階梯用藥原則給予口服藥物治療。 結果 : 深部痛點阻滯組及對照組兩組患者經治療后疼痛控制均較理想(深部痛點阻滯組VAS13, 對照組VAS17),但是深部痛點阻滯組嗎啡用量明顯少于對照組(嗎啡日平用量深部痛點阻滯組為335mg, 對照組為15287 mg)。便秘的發生率深部痛點阻滯組為5384%,對照組為7692%。 結論 : 深部痛點阻滯能較好的控制頑固性癌痛,同時可明顯減少嗎啡的用量,副作用相對發生要少。
Abstract: Objective: To investigate the effect of the deeppressed pain points injection on the refractory cancer pain and provide reference for relieving the cancer pain. Methods : One hundred and fiftysix patients with refractory cancer pain were diagnosed by the soft tissue surgery,finding the pain point by pressing deeply,the patients with deeppressed pain points were divided into deeppressed pain points injection group and control group randomly, The patients in deeppressed pain points injection group were treated with deeppressed pain points injection; the patients in control group were treated with drugs according with the WHO analgesic ladder. Results : The patients in deeppressed pain points injection group got the same pain relief as those in control group (VAS 13 in deeppressed pain points injection group, 17 in control group ),but the daily dose of morphine in deeppressed pain points injection group was less than that incontrol group (morphine 335mg/day in deeppressed pain points injection group,15287mg/day in control group ) significantly. There was 5384% patients with constipation in deeppressed pain points injection group, 7692% in control group. Conclusion : The refractory cancer pain can be controlled effectively by the deeppressed pain point injection and the daily dose of morphine to control the cancer pain is decreased significantly. The side effect in deeppressed pain points injection group was less than that in control group.
引用本文： 李信明,李定明,蔣鵬飛,魏安寧. 深部痛點阻滯在頑固性癌痛中的臨床研究. 華西醫學, 2009, 24(10): 2554-. doi: 復制